State of Wisconsin Investment Board’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.57M | Sell |
32,189
-4,382
| -12% | -$396K | 0.01% | 1262 |
|
|
2026
Q1 | $3.18M | Buy |
36,571
+492
| +1% | +$47.8K | 0.01% | 1172 |
|
|
2025
Q4 | $3.86M | Sell |
36,079
-4,697
| -12% | -$498K | 0.01% | 1113 |
|
|
2025
Q3 | $4.12M | Buy |
40,776
+5,068
| +14% | +$471K | 0.01% | 1031 |
|
|
2025
Q2 | $2.26M | Buy |
35,708
+2,683
| +8% | +$164K | 0.01% | 1250 |
|
|
2025
Q1 | $1.75M | Buy |
33,025
+763
| +2% | +$42.3K | ﹤0.01% | 1292 |
|
|
2024
Q4 | $1.81M | Sell |
32,262
-191
| -0.6% | -$10.6K | ﹤0.01% | 1324 |
|
|
2024
Q3 | $1.7M | Sell |
32,453
-6,974
| -18% | -$334K | ﹤0.01% | 1370 |
|
|
2024
Q2 | $1.62M | Buy |
39,427
+6,123
| +18% | +$244K | ﹤0.01% | 1386 |
|
|
2024
Q1 | $1.44M | Sell |
33,304
-4,110
| -11% | -$180K | ﹤0.01% | 1327 |
|
|
2023
Q4 | $1.72M | Sell |
37,414
-1,223
| -3% | -$38.6K | ﹤0.01% | 1265 |
|
|
2023
Q3 | $886K | Sell |
38,637
-4,179
| -10% | -$93.6K | ﹤0.01% | 1442 |
|
|
2023
Q2 | $706K | Buy |
42,816
+1,205
| +3% | +$21.8K | ﹤0.01% | 1626 |
|
|
2023
Q1 | $742K | Buy |
41,611
+853
| +2% | +$21.4K | ﹤0.01% | 1640 |
|
|
2022
Q4 | $1.19M | Buy |
40,758
+2,253
| +6% | +$57.9K | ﹤0.01% | 1439 |
|
|
2022
Q3 | $943K | Sell |
38,505
-169,196
| -81% | -$3.15M | ﹤0.01% | 1572 |
|
|
2022
Q2 | $862K | Buy |
207,701
+109,801
| +112% | +$601K | ﹤0.01% | 1734 |
|
|
2022
Q1 | $1.13M | Buy |
97,900
+49,500
| +102% | +$434K | ﹤0.01% | 1614 |
|
|
2021
Q4 | $483K | Hold |
48,400
| – | – | ﹤0.01% | 1697 |
|
|
2021
Q3 | $632K | Hold |
48,400
| – | – | ﹤0.01% | 1613 |
|
|
2021
Q2 | $948K | Hold |
48,400
| – | – | ﹤0.01% | 1469 |
|
|
2021
Q1 | $1.03M | Hold |
48,400
| – | – | ﹤0.01% | 1358 |
|
|
2020
Q4 | $1.44M | Sell |
48,400
-6,000
| -11% | -$152K | ﹤0.01% | 1255 |
|
|
2020
Q3 | $1.18M | Buy |
54,400
+4,100
| +8% | +$94K | ﹤0.01% | 1258 |
|
|
2020
Q2 | $1.12M | Buy |
50,300
+2,600
| +5% | +$50.7K | ﹤0.01% | 1221 |
|
|
2020
Q1 | $726K | Buy |
47,700
+13,300
| +39% | +$238K | ﹤0.01% | 1261 |
|
|
2019
Q4 | $790K | Hold |
34,400
| – | – | ﹤0.01% | 1296 |
|
|
2019
Q3 | $743K | Buy |
34,400
+13,300
| +63% | +$285K | ﹤0.01% | 1208 |
|
|
2019
Q2 | $464K | Buy |
21,100
+500
| +2% | +$12.6K | ﹤0.01% | 1345 |
|
|
2019
Q1 | $565K | Buy |
20,600
+4,800
| +30% | +$138K | ﹤0.01% | 1318 |
|
|
2018
Q4 | $425K | Buy |
15,800
+3,200
| +25% | +$88.4K | ﹤0.01% | 1362 |
|
|
2018
Q3 | $368K | Hold |
12,600
| – | – | ﹤0.01% | 1447 |
|
|
2018
Q2 | $394K | Buy |
+12,600
| New | +$345K | ﹤0.01% | 1385 |
|
Other funds holding RYTM
RCM
BBA
PA
State of Wisconsin Investment Board's RYTM Position: Q2 2026 in Review
State of Wisconsin Investment Board reduced its Rhythm Pharmaceuticals (RYTM) stake by 12% in Q2 2026, selling an estimated $396K and leaving 32,189 shares worth $3.57M. The position accounts for 0.01% of the portfolio, ranked #1262.
State of Wisconsin Investment Board first reported a position in RYTM in Q2 2018 and has held it in 33 quarters since. The position peaked at $4.12M in Q3 2025. 302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.
- State of Wisconsin Investment Board held 32,189 shares of Rhythm Pharmaceuticals worth $3.57M as of Q2 2026.
- State of Wisconsin Investment Board sold 4,382 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $396K.
- Rhythm Pharmaceuticals made up 0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1262 holding.
- State of Wisconsin Investment Board first reported a position in Rhythm Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
- State of Wisconsin Investment Board's Rhythm Pharmaceuticals position peaked at $4.12M in Q3 2025.
- 302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.